Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSupply@me Cap Regulatory News (SYME)

  • This share is currently suspended. It was suspended at a price of 0.0026

Share Price Information for Supply@me Cap (SYME)

Share Price is delayed by 15 minutes
Get Live Data
0.0026    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: £1.87m
SYME Live PriceLast checked at - London Stock Exchange

Intraday Supply@me Cap Share Chart

Funding update

18 Sep 2025 07:00

RNS Number : 7799Z
Supply@ME Capital PLC
18 September 2025
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF REGULATION 2014/596/EU, WHICH IS PART OF UNITED KINGDOM DOMESTIC LAW PURSUANT TO THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS (SI 2019/310) ("UK MAR"). UPON THE PUBLICATION OF THIS ANNOUNCEMENT, THIS INSIDE INFORMATION (AS DEFINED IN UK MAR) IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

18 September 2025

Supply@ME Capital plc

(The "Company" or "SYME")

Funding update

 

SYME, the fintech business which provides an innovative fintech platform (the "Platform") for use by manufacturing and trading companies to access Inventory Monetisation© ("IM") solutions enabling their businesses to generate cashflow, announces the following update in respect of the US$5,150,000 on-demand convertible funding facility signed on 18 March 2025, and amended on 10 June 2025 and 29 August 2025, with Nuburu Inc., a NYSE listed (NYSE American: BURU) high-tech company of which Alessandro Zamboni, a director of the Company, is Executive Chairman ("BURU") (the "Amended On-Demand Facility").

As set out in the announcement dated 1 September 2025, SYME was due to receive the next tranche under the Amended On-Demand Facility of US$2,000,000 on or before 12 September 2025. However, as set out in the announcement dated 15 September 2025, this amount had not been received as at that date.

The Company is pleased to confirm that this amount of US$2,000,000 was received from BURU on 17 September 2025. The latest communication that the board of directors of SYME has had with BURU, via Alessandro Zamboni, is that BURU currently expects to make the final payment of US$2,198,000 on or before 31 October 2025 in line with the payment schedule included in the Amended On-Demand Facility. The Company will issue further updates as required.

Alessandro Zamboni, the Chief Executive Officer of the Company, is a related party in connection with the Amended On-Demand Facility due to the fact that he is also the Executive Chairman of BURU.

For the purposes of UK MAR, the person responsible for arranging release of this announcement on behalf of SYME is Alessandro Zamboni, CEO.

Notes

SYME and its operating subsidiaries provide its Platform for use by manufacturing and trading companies to access inventory trade solutions enabling their businesses to generate cashflow, via a non-credit approach and without incurring debt. This is achieved by their existing eligible inventory being added to the Platform and then monetised via purchase by third party Inventory Funders. The inventory to be monetised can include warehoused goods waiting to be sold to end-customers or goods that are part of a typical import/export transaction.

Contacts

Albert Ganyushin, Chairman, Supply@ME Capital plc, investors@supplymecapital.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDUBVBRVKUKAAR
Date   Source Headline
13th Sep 20227:00 amRNSHolding in Company
12th Sep 20227:00 amRNSInaugural IM transaction executed
6th Sep 20222:00 pmRNSPrice Monitoring Extension
5th Sep 202211:05 amRNSSecond Price Monitoring Extn
5th Sep 202211:00 amRNSPrice Monitoring Extension
5th Sep 20227:00 amRNSIssue of Equity & Total Voting Rights
31st Aug 20227:00 amRNSIssue of Equity & Total Voting Rights
30th Aug 20227:12 amRNSHolding in Company
23rd Aug 20224:40 pmRNSSecond Price Monitoring Extn
23rd Aug 20224:35 pmRNSPrice Monitoring Extension
18th Aug 20227:00 amRNSResult of Open Offer
17th Aug 202211:05 amRNSPDMR/PCA Shareholding: Stock Loans Updates
15th Aug 20224:41 pmRNSSecond Price Monitoring Extn
15th Aug 20224:36 pmRNSPrice Monitoring Extension
10th Aug 20224:41 pmRNSSecond Price Monitoring Extn
10th Aug 20224:35 pmRNSPrice Monitoring Extension
9th Aug 20227:00 amRNSFirst IM Transaction: Binding commitment signed
8th Aug 20222:00 pmRNSPrice Monitoring Extension
1st Aug 20225:15 pmRNSTotal Voting Rights
1st Aug 20228:00 amRNSHolding in Company
29th Jul 20224:41 pmRNSSecond Price Monitoring Extn
29th Jul 20224:36 pmRNSPrice Monitoring Extension
29th Jul 20227:00 amRNSUpdate on first Inventory Monetisation Transaction
25th Jul 20227:00 amRNSDirectors/PDMR Shareholding
22nd Jul 20227:00 amRNSOpen Offer & Business Update
18th Jul 20221:13 pmRNSThird tranche of shares issued to Venus Capital
30th Jun 20224:29 pmRNSResult of AGM
28th Jun 20227:00 amRNSStrategic Alliance with VeChain Foundation
23rd Jun 20227:00 amRNSTradeflow and DP World complete first transaction
14th Jun 20227:00 amRNSNotice of AGM: CORRECTION
13th Jun 20227:00 amRNSAppointment of Independent Non-Executive Director
10th Jun 20227:00 amRNSNotice of AGM
6th Jun 20224:17 pmRNSPosting of 2021 Annual Report & Notice of AGM
6th Jun 20227:00 amRNSAppointment of new independent Non-Executive Chair
31st May 20227:00 amRNS2021 Annual Financial Report
25th May 20223:01 pmRNSTotal Voting Rights
10th May 20224:38 pmRNSSecond tranche of shares issued to Venus Capital
10th May 20227:00 amRNSSecond tranche of shares issued to Venus Capital
3rd May 20229:06 amRNSSecond Price Monitoring Extn
3rd May 20229:00 amRNSPrice Monitoring Extension
27th Apr 20222:06 pmRNSSecond Price Monitoring Extn
27th Apr 20222:00 pmRNSPrice Monitoring Extension
27th Apr 202211:05 amRNSSecond Price Monitoring Extn
27th Apr 202211:00 amRNSPrice Monitoring Extension
27th Apr 20229:05 amRNSSecond Price Monitoring Extn
27th Apr 20229:00 amRNSPrice Monitoring Extension
27th Apr 20227:01 amRNSCapital Enhancement Plan & Revised Date of Results
19th Apr 20227:00 amRNSBoard Change
12th Apr 20229:06 amRNSSecond Price Monitoring Extn
12th Apr 20229:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.